Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain)

Amyloid

Volumn 12, Issue 1, 2005, Pages 54-61

  Munar Qués, Miguel ^a   Saraiva, Maria J M ^b   Viader Farré, Carlos ^a   Zabay Becerril, José María ^a   Mulet Ferrer, Juana ^a  

^a Grupo de Estudio de la PAF   (Spain)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Anticipation of age at onset; Familial amyloid polyneuropathy; Haplotype I; Hereditary amyloidosis; TTRVal30Met mutation

Indexed keywords

METHIONINE; VALINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BALEARIC ISLANDS; BRAZIL; DISEASE DURATION; EXTRACHROMOSOMAL INHERITANCE; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILY HISTORY; FATHER; FEMALE; FERTILITY; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INHERITANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATERNAL INHERITANCE; PORTUGAL; PRIORITY JOURNAL; SEX RATIO; SPAIN; SWEDEN; VERTICAL TRANSMISSION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PENETRANCE; PREVALENCE; SPAIN; SURVIVAL RATE; TIME FACTORS;

EID: 21244433163     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506120500032741     Document Type: Article

References (29)

1. Andrade C. A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of peripheral nerves. Brain 1952;75:408-427.
2. Connors LH, Lim A, M, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TrR) variants. Amyloid: J Protein Folding Disord 2003;10:160-184.
3. Barraquer Ferré L. Estudios de Neurología Clínica. Barcelona: Janés; 1952. pp 427-432, 438-439.
4. Costa PP. Polineuropatia amiloidótica familiar. Boletim do Hospital (HGSA) 1976;1:71-75.
5. Santamaría Arández A. Alba del Reino de Mallorca. In: Mascaró Pasarius J, editor. Historia de Mallorca Tomo III. Palma de Mallorca: Gráficas Miramar; 1970. pp 1-84.
6. Sevillano Colom F. De Venecia a Flandes (vía Mallorca y Portugal, siglo XIV). Boletín de la Sociedad Arqueológica Luliana 1968;33:1-33.
7. Yoshioka K, Furuya H, Sasaki H, Saraiva MJM, Costa PP, Sakaki Y. Haplotype analysis of familial amyloidotic polyneuropathy. Evidence of multiple origins of the Val-Met mutation most common to the disease. Human Genetics 1989;82:9-13.
8. Almeida MR, Aoyama-Oishi N, Sakaki Y, Holmgren G, Ulf D, Ferlini A, Salvi F, Munar-Qués M, Benson MD, Skinner M, Costa PP, Saraiva MJ. Haplotype analysis of common transthyretin mutations. Hum Genet 1995;96:350-354.
9. Saraiva MJM, Alves IL, Costa PP. Simplified method for screening populations at risk for transthyretin Met30-associated familial amyloidotic polyneuropathy. Clin Chem 1989;35:1033-1035.
10. Torres MF, Almeida MR, Saraiva MJ. TTR exon scanning in peripheral neuropathies. Neuromusc Disord 1995;5:187-191.
11. Munar-Qués M, Costa PP, Saraiva MJM. The Majorcan focus of familial amyloidotic polyneuropathy type I. Arquivos de Medicina 1990;3 (Suppl):13-18.
12. Munar-Qués M, Costa PP, Saraiva MJM, Viader-Farré C, Munar-Bernat C, Cifuentes-Luna C, Forteza-Alberti JF. Familial amyloidotic polyneuropathy TTR Met 30 in Majorca (Spain). Amyloid: Int J Exp Clin Invest 1997;4:181-186.
13. Falcao de Freitas A. Aspectos clínicos da polineuropatia amiloidótica familiar (tipo Andrade). Boletim do Hospital (HGSA) 1976;1:17-25.
14. Bastos Lima A, Martins da Silva A. Clinical evaluation of late onset cases in type I (Andrade) amyloid polyneuropathy. In: Glenner GG, Costa PP, Falcao de Freitas A, editors. Amyloid and amyloidosis. Oxford: Excerpta Medica; 1980. pp 99-105.
15. Saraiva MJM, Costa PP, Goodman DS. Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy. Neurology 1986;36:1413-1417.
16. Ribeiro I, Coutinho P. Late-onset forms of Familial Amyloid Polyneuropathy (Portuguese type): a reappraisal. In: Tsobe T, Araki S, Uchino F, Kito S, Tsubura E, editors. Amyloid and amyloidosis. New York and London: Plenum Press; 1988. pp 435-439.
17. Coelho T, Sousa A, Lourenço E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 1994;31:293-299.
18. Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi M, Yanagisawa N, Kobayashi T, Tsukagoshi H, Ito N, Yokota T. Hereditary generalized amyloidosis with polineuropathy. Clinicopathological study of 65 Japanese patients. Brain 1987;110:315-337.
19. Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999;122:1951-1962.
20. Ikeda S, Nakazato M, Ando, Sobue G. Familial transthyretin-type amyloid polyneuropathy. Clinical and genetic heterogeneity. Neurology 2002;58:1001-1007.
21. Munar-Qués M, Pedrosa JL, Coelho T, Gusmao L, Seruca R, Amorim A, Sequeiros J. Two pairs of proven monozygotic twins discordant for familial amyloid neuropathy (FAP) TTR Met 30. J Med Genet 1999;36:629-632.
22. Sousa A, Coelho T, Lobato L, Sequeiros J. Anticipation of age-of-onset in familial amyloidotic polineuropathy (Portuguese type). In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P, editors. Amyloid and amyloidosis. Dordrecht: Kluwer Academic Publishers;1991. pp 694-697.
23. Sousa A. A variabilidade fenotípica da polineuropatia amiloidotica familiar: um estudo de genética quantitativa em Portugal e na Suecia. Doctoral Thesis. University of Porto, 1995.
24. Araki S, Ikegawa S, Okamoto N, Murakami T, Ando Y, Yi S. Epidemiological study of familial amyloidotic polyneuropathy (FAP) in Kumamoto focus, Japan. Neuromusc Disord 1996;6 (Suppl 1):39.
25. Novis SAP, André C, Cruz MW. Familial amyloidotic polyneuropathy of the Portuguese type (Type I) in Rio de Janeiro, Brazil. Clinical features in 127 patients from 22 families. Arquivos de Medicina 1990;3 (Suppl):263-266.
26. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (North of Portugal). Am J Med Genet 1995;60:512-521.
27. Munar-Qués M, Coelho T, Sequeiros J, Sousa A. Genetic epidemiology of familial amyloid polyneuropathy (FAP-Met30) in Majorca (Spain). Presented at the 4th International Symposium on familial amyloidotic polyneuropathy and other transthyretin disorders and The 3rd International Workshop on liver transplantation in familial amyloid polyneuropathy. Umea, 3-5 June 1999. p 27.
28. Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 1998;35:23-30.
29. Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet 1993; 1(30):388-392.